{"filing":{"accession_number":"0001193125-26-272890","cik":"0001789972","ticker":"CGEM","company_name":"Cullinan Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-16","report_date":null,"primary_document":"cgem-20260616.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526272890/cgem-20260616.htm"},"events":[{"id":11399,"run_id":10006,"accession_number":"0001193125-26-272890","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 disclosure presents the results of the Annual Meeting of Stockholders held on June 16, 2026, with voting outcomes for three proposals: election of two Class III directors (Nadim Ahmed and Stephen Webster), ratification of KPMG LLP as independent auditor, and an advisory vote on executive compensation. The filing directly matches the shareholder_vote_results event type and is material to investors as it confirms board composition and auditor appointment.","company_name":"Cullinan Therapeutics, Inc.","ticker":"CGEM","filing_date":"2026-06-16","form":"8-K","submitted_at":null,"items":[{"id":7981,"accession_number":"0001193125-26-272890","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the results of the Annual Meeting of Stockholders held on June 16, 2026, with voting outcomes for three proposals: election of two Class III directors (Nadim Ahmed and Stephen Webster), ratification of KPMG LLP as independent auditor, and an advisory vote on executive compensation. The filing directly matches the shareholder_vote_results event type and is material to investors as it confirms board composition and auditor appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-16T21:19:05.609646+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7981,"accession_number":"0001193125-26-272890","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the results of the Annual Meeting of Stockholders held on June 16, 2026, with voting outcomes for three proposals: election of two Class III directors (Nadim Ahmed and Stephen Webster), ratification of KPMG LLP as independent auditor, and an advisory vote on executive compensation. The filing directly matches the shareholder_vote_results event type and is material to investors as it confirms board composition and auditor appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-16T21:19:05.609646+00:00","company_name":"Cullinan Therapeutics, Inc.","ticker":"CGEM","filing_date":"2026-06-16"}]}